Communication about an Ongoing Safety Review of Stimulant Medications used in Children with Attention-Deficit/Hyperactiv
This is a discussion on Communication about an Ongoing Safety Review of Stimulant Medications used in Children with Attention-Deficit/Hyperactiv within the FDA News forum, part of the Industry News and Updates category; The U.S. Food and Drug Administration is providing its perspective on data published today in the American Journal of ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
06-15-2009, 01:58 PM
|
|||
|
|||
Communication about an Ongoing Safety Review of Stimulant Medications used in Children with Attention-Deficit/Hyperactiv
The U.S. Food and Drug Administration is providing its perspective on data published today in the American Journal of Psychiatry on the potential risks of stimulant medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Follow-up to the March 27, 2008, Communication about the Ongoing Safety Review of Montelukast (Singulair) | industry_news | FDA News | 0 | 01-13-2009 03:42 PM |
| FDA updates the Early Communication about the Ongoing Safety Review of Bisphosphonates | industry_news | FDA News | 0 | 11-12-2008 11:48 AM |
| Epoetin alfa - Early Communication about an Ongoing Safety Review | industry_news | FDA News | 0 | 09-26-2008 12:42 PM |
| FDA issues an Early Communication About an Ongoing Safety Review of Vytorin, Zocor, and Zetia. | industry_news | FDA News | 0 | 08-22-2008 03:44 PM |
| FDA issues an Early Communication about an Ongoing Safety Review for Botox | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
© 2008 DrugManagementForum™ powered by |
 |